Allianz Asset Management
RGNX icon

Allianz Asset Management’s Regenxbio RGNX Stock Holding History

Allianz Asset Management’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-31,800
Closed -$246K – 2337
2024
Q4 		$246K Sell
31,800
-7,500
-19% -$70.4K ﹤0.01% 2057
2024
Q3 		$412K Sell
39,300
-53,300
-58% -$650K ﹤0.01% 1904
2024
Q2 		$1.08M Buy
+92,600
New +$1.44M ﹤0.01% 1560
2020
Q2 		– Sell
-15,678
Closed -$508K – 2518
2020
Q1 		$508K Sell
15,678
-22,724
-59% -$947K ﹤0.01% 2057
2019
Q4 		$1.57M Buy
38,402
+22,846
+147% +$902K ﹤0.01% 1981
2019
Q3 		$554K Sell
15,556
-85,201
-85% -$3.45M ﹤0.01% 2344
2019
Q2 		$5.18M Buy
100,757
+33,944
+51% +$1.69M ﹤0.01% 1490
2019
Q1 		$3.83M Buy
66,813
+41,987
+169% +$2.08M ﹤0.01% 1573
2018
Q4 		$1.04M Sell
24,826
-65,899
-73% -$3.87M ﹤0.01% 2013
2018
Q3 		$6.85M Sell
90,725
-18,780
-17% -$1.35M 0.01% 1418
2018
Q2 		$7.86M Buy
109,505
+67,296
+159% +$3.21M 0.01% 1352
2018
Q1 		$1.26M Buy
+42,209
New +$1.23M ﹤0.01% 2116

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Allianz Asset Management's RGNX Position: Q1 2025 in Review

Allianz Asset Management sold out of Regenxbio (RGNX) in Q1 2025, closing a stake of 31,800 shares — an estimated $246K sold.

Allianz Asset Management first reported a position in RGNX in Q1 2018 and held it in 12 quarters. The position peaked at $7.86M in Q2 2018. 164 funds tracked by Wall St. Rank hold RGNX as of Q1 2025.

  • Allianz Asset Management reported no remaining Regenxbio position as of Q1 2025 after selling out during the quarter.
  • Allianz Asset Management sold 31,800 Regenxbio shares in Q1 2025, an estimated $246K.
  • Allianz Asset Management first reported a position in Regenxbio in Q1 2018 and held it in 12 quarters.
  • Allianz Asset Management's Regenxbio position peaked at $7.86M in Q2 2018.
  • 164 funds tracked by Wall St. Rank held Regenxbio as of Q1 2025.

Based on Allianz Asset Management's 13F filing for Q1 2025, filed 5 May 2025.